Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Canada/Amycretin / Zenagamtide
Purchase and availability checkAmycretin / Zenagamtide in Canada

Can you buy Amycretin in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Amycretin / Zenagamtide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Canada
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Amycretin in Canada?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Amycretin / Zenagamtide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Amycretin / Zenagamtide in Canada?

Resolve the exact identity of Amycretin / Zenagamtide through AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 from ClinicalTrials.gov. Then search Drug Product Database from Health Canada for the destination product record and Choosing a safe online pharmacy from Health Canada for the seller, establishment, or supply route in Canada. A match in one record does not replace the other two checks.

03

Does an online listing prove Amycretin / Zenagamtide is authorized or available in Canada?

No. A page using the name Amycretin / Zenagamtide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Canada, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Amycretin / Zenagamtide clinical trials in Canada

5 study records currently list 44 locations in this country, including 25 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
5
Listed locations
44
Recruiting locations
25
Records with local recruiting sites
4
NCT07567001
Study-wide statusRecruiting

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Listed locations
27
Recruiting locations
11
Registry update
2026-07-15
NCT07339423
Study-wide statusRecruiting

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Listed locations
5
Recruiting locations
5
Registry update
2026-07-09
NCT07481630
Study-wide statusRecruiting

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Listed locations
5
Recruiting locations
4
Registry update
2026-07-09
NCT07509307
Study-wide statusRecruiting

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Listed locations
6
Recruiting locations
5
Registry update
2026-07-09
NCT06461039
Study-wide statusCompleted

A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

Listed locations
1
Recruiting locations
0
Registry update
2025-05-08
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Canada, or keep Amycretin / Zenagamtide fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

Amycretin / Zenagamtide in North America

Amycretin / Zenagamtide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Amycretin / Zenagamtide is an investigational clinical program. No seller listing in Canada can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414

AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414 ↗

Drug Product Database

Drug Product Database is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drug Product Database ↗

Choosing a safe online pharmacy

Choosing a safe online pharmacy is maintained by Health Canada. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Choosing a safe online pharmacy ↗
Canada / Country guide

Canada market context.

Health Canada warned in April 2026 that unauthorized injectable peptide drugs sold online can cause serious harm and said products labelled for research use should not be used as drugs.

  • Health Canada’s April 2026 advisory names BPC-157, GHK-Cu, MOTS-C, and other unauthorized injectable peptides among examples it seized.
  • The federal Drug Product Database can be searched by DIN, product, ingredient, company, status, route, and dosage form.
  • Pharmacy licensing is provincial or territorial, so a Canadian address must still be matched to the appropriate regulator’s public record.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Check the DIN

Authorized drugs sold in Canada carry an eight-digit Drug Identification Number that can be checked in Health Canada’s database.

02

Verify the pharmacy

Use the pharmacy regulatory authority for the province or territory where the business is established, including for online sellers.

03

Separate research labels

Do not treat a ‘research use only’ label, imported parcel, or wellness claim as a prescription or authorization pathway.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
AMAZE 7 zenagamtide versus semaglutide Phase 3 study - NCT07668414ClinicalTrials.gov
02
Drug Product DatabaseHealth Canada
03
Choosing a safe online pharmacyHealth Canada
04
Unauthorized injectable peptide warningHealth Canada
05
Zenagamtide study search in CanadaClinicalTrials.gov
06
NCT07567001: A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityClinicalTrials.gov
07
NCT07339423: AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightClinicalTrials.gov
08
NCT07481630: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainClinicalTrials.gov
09
NCT07509307: AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainClinicalTrials.gov
10
NCT06461039: A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become PregnantClinicalTrials.gov
Audit and handoff

Keep the exact record attached.